Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gastroenterology » Liver » Neoplasms 21. August 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Hepatitis
Liver Cirrhosis
Neoplasms
Portal Hypertension
Others
Gastrointestinal
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3862  Previews Next
   
   Articles 1 - 20 / 77226  
   
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.
Lancet
Sun HC, Zhu XD, Shen F, Song TQ, Bai XL, Zeng YY, Chen MS, Huang ZY, Cai JQ, Gao J, Kuang M, Li DY, Xing BC, Li XC, Wen TF, Peng T, Wang YD, Liu LX, Huang C, Shi YH, Huang XW, Wang K, Gao Q, Zhou J, Fan J.
PMID: 42624156 [PubMed - indexed for MEDLINE]


The role of platelets in the hepatocellular carcinoma immune microenvironment and their clinical prospects: a comprehensive review.
Med Oncol
Yang Z, Qi L, Liu D, Wang W, Lu J.
PMID: 42622777 [PubMed - indexed for MEDLINE]


Camrelizumab-associated MG-like ocular neuromuscular toxicity after PD-1 inhibitor rechallenge in metastatic hepatocellular carcinoma: a case report with serial muscle injury-related biomarker changes.
Front Immunol
Li J, Chen M, Wang L, Bo K, Chen M, Jiang H.
PMID: 42620508 [PubMed - indexed for MEDLINE]


A dual-level Bayesian network meta-analysis of first-line immunotherapy in advanced hepatocellular carcinoma: strategy-level and regimen-level evidence.
Front Immunol
Zhang Q, Hu Y, Ge Y, Wang R.
PMID: 42620506 [PubMed - indexed for MEDLINE]


Efficacy and safety of transarterial chemoembolization combined with donafenib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus: a dual-center, retrospective propensity score-matched analysis.
Front Immunol
Zhang Q, Qing H, Lei Z, Xie X.
PMID: 42620307 [PubMed - indexed for MEDLINE]


Prevention, surveillance, and early detection of hepatocellular carcinoma - a Brazilian multidisciplinary consensus.
Arq Bras Cir Dig
Coimbra FJF, Godoy AL, Fernandes PHS, Castro Neto HFE, Pinheiro RN, Boin IFSF, Andraus W, Tustumi F, Amaral PCGD, Brandão-Mello CE, Braun AC, Braghiroli MI, Bredt LC, Caparroz C, Carrilho FJ, Cunha GM, Diniz AL, Forte DN, Garcia JHP, Genzini T, Correia MM, Oliveira CVC, Kalil AN, Lima AS, Martins GLP, Rocha CM, Menezes MR, Motta-Leal-Filho JMD, Murad Júnior M, Peixoto RD, Pinheiro RSN, Rezende MB, Ribeiro HSC, Martins MR, Rocha Filho DRD, Rosa AA, Szutan LA, Torres OJM, D'Albuquerque LAC, Mattos ÂA, Coutinho AK, Herman P, Oliveira AF.
PMID: 42615769 [PubMed - indexed for MEDLINE]


Early-Onset Colorectal Cancer With Liver-Only Metastases: A Retrospective Cohort Study Integrating Prospectively Collected Real-World Clinical and Molecular Data From an Australian National Database (2009-2024) to Guide Treatment Planning.
Med J Aust
Barreto SG, Karapetis CS, Ullah S, Burge M, Caird S, Campbell A, Jalali A, Jennens R, Khattak MA, Lee B, Lim SH, Mendis S, Nott L, Price TJ, Shapiro JD, Tie J, Torres J, Williams C, Wong R, Wong V, Gibbs P.
PMID: 42613959 [PubMed - indexed for MEDLINE]


Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma: Summary of the First Annual Paris International Liver Meeting 2026.
Liver Int
Younossi ZM, Papatheodoridis G, Tsochatzis E, Buti M, Rimassa L, Pinzani M, Lleo A, Shawcross D, Tacke F, Wong VW, Zelber-Sagi S, Kremer AE, J Pinato D, M Llovet J, Angeli P, Asselah T, Pugliese N, Caussy C, Berzigotti A, Lampertico P, Cornberg M, Israelsen M, Gines P, Lens S, Hagström H, Trauner M, Brennan P, Boursier J, Brunetto M, Thursz M, Bugianesi E, Carette C, Degasperi E, Durand F, Dufour JF, Francque S, Francoz C, Gautier JF, Hernandez-Evole H, Jones D, Michel M, Moreno C, Mouillot T, Parlati L, Pawlotsky JM, Rautou PE, Reiberger T, Roux O, Betel M, Thabut D, Noureddin M, Vilgrain V, Vuille-Lessard E, Yilmaz Y, Gadano A, Ratziu V, Schattenberg JM, Bataller R, Serfaty L, Thiele M, Aghemo A, Castera L.
PMID: 42613687 [PubMed - indexed for MEDLINE]


Ligand-Engineered Mn-Cysteine as a Potent Laccase Mimic for CRISPR/Cas12a Electrochemical Biosensing of Hepatocellular Carcinoma Biomarkers.
ACS Nano
Zhou Y, Li H, Chen M, Ye J, Yan Y, Yang L, Meng T, Jiao D, Wang D, Zhu L, Yang X.
PMID: 42611239 [PubMed - indexed for MEDLINE]


ABO-incompatibility and hepatocellular carcinoma recurrence after living donor liver transplantation: stratified by tumor burden.
Transpl Int
Kang WH, Hwang S, Moon DB, Kim KH, Ahn CS, Ha TY, Song GW, Jung DH, Park GC, Yoon YI, Na BG, Kim SH, Kim SM, Lee SG.
PMID: 42609286 [PubMed - indexed for MEDLINE]


Liver sinusoidal endothelial cells in liver diseases and hepatocellular carcinoma: molecular mechanisms, physiology, and therapies.
Mol Biomed
Yan M, Cui Y, Xiang Q.
PMID: 42606689 [PubMed - indexed for MEDLINE]


Cuproptosis in hepatocellular carcinoma: bridging copper homeostasis with therapeutic horizons.
Mol Biol Rep
Fan S, Wang A, Peng R, Cao J, Tu D, Su B, Zhang J, Jin S, Jiang G, Zhang C, Bai DS.
PMID: 42606662 [PubMed - indexed for MEDLINE]


Risk of Liver Cancer From Major Causes Compared to Smoking and Lung Cancer: A Systematic Review and Meta-Analysis.
J Viral Hepat
Wallace C, Razavi-Shearer D, Hall S, Asselah T, James C, Kondili LA, Kottilil S, Low-Beer D, Mathur P, Tanaka J, Torres HA, Razavi H.
PMID: 42605247 [PubMed - indexed for MEDLINE]


A novel adrenomedullin receptor signaling-based prognostic model predicts immunosuppressive microenvironment and informs therapeutic stratification in hepatocellular carcinoma: A retrospective bioinformatics study.
Medicine (Baltimore)
Zhu D, Zhong S, Hong J, Lu C, Zhuang L.
PMID: 42601689 [PubMed - indexed for MEDLINE]


Efficacy analysis of icaritin combined with transarterial chemoembolization in hepatocellular carcinoma stratified by different child-pugh classes.
Front Immunol
Xu J, Xing Y, Zhao F, Tang B, Li X, Cun J, Lu H, Xia X, Fan H, Gu Y, Xu T.
PMID: 42597629 [PubMed - indexed for MEDLINE]


AI-assisted ascites volumetry for prognostic stratification in HCC treated with Atezolizumab/Bevacizumab.
Cancer Imaging
Moos M, Bender D, Foerster F, Wiesmann L, Weinmann A, Kloeckner R, Scholz C, Euler A, Mähringer-Kunz A, Bäuerle T, Stoehr F, Hahn F, Müller L.
PMID: 42596020 [PubMed - indexed for MEDLINE]


Cryoablation versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
Int J Hyperthermia
Mao K, Wang Y, Yao W, Ding J, Ye Z, Ye Y, Zhu R.
PMID: 42595456 [PubMed - indexed for MEDLINE]


Prognostic Value of Liver Function and Tumor Burden Scores in Patients with HCC After Transarterial Radioembolization - Retrospective Single Center Analysis.
J Gastrointest Cancer
Schindler A, Beeskow A, Fischer J, Ebel S, Denecke T, Seehofer D, Lincke T, Sabri O, Berg T, van Bömmel F.
PMID: 42593561 [PubMed - indexed for MEDLINE]


Artificial Intelligence for Molecular Biomarker Identification in Gastrointestinal and Hepatobiliary Cancers.
Int J Mol Sci
Jang HJ, Yim K, Lee SH.
PMID: 42589623 [PubMed - indexed for MEDLINE]


Metabolic Reprogramming at the Tumor-Immune Interface in Hepatocellular Carcinoma.
Cells
Zhao W, Li P.
PMID: 42587767 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 77226    Page 1 of 3862  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1